A randomised controlled trial of breast cancer patients treated with chemotherapy in a hospital day unit or at home; an analysis of cost and patient reported outcomes

A/Prof Suzanne Robinson0 个研究点目标入组 130 人开始时间: 2015年3月2日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•The inclusion criteria for study participants are: scheduled to receive chemotherapy for breast cancer and suitable for day-case administration; expect to receive at least four cycles of chemotherapy; are aged 18 years or older; WHO performance status of 0,1 or 2, and are able to provide written informed consent. Patients have received two doses of chemotherapy in the hospital-based chemotherapy unit without adverse events prior to enrolment in the study.

•Participants who are <18 years old; Those who are unable to give informed consent for any reason; Chemotherapy regimens requiring more than 2 hours administration time; Concurrent uncontrolled medical illness likely to interfere with compliance and a serious adverse event (defined as CTCAE v4 GIII/IV adverse event) during administration of cycles 1 or 2; Patients who suffer either anaphylactic or severe hypersensitivity reaction in the first two cycles of treatment in the hospital day unit; only female patients will be recruited.

发起方

A/Prof Suzanne Robinson